Vertex Pharmaceuticals
Search results
Moderna's mission is to deliver the greatest possible impact to people through mRNA medicines.
Moderna’s goal is to deliver on the promise of mRNA science to create a new generation of transformative medicines for patients.
We’re making biotech history. Messenger RNA is not new technology, but we are discovering new ways to use it to treat and prevent illnesses and diseases. Since our founding in 2010, we have worked to build the industry's leading mRNA technology platform.
Moderna, Inc. (/ m ə ˈ d ɜːr n ə / mə-DUR-nə) is a pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to carry instructions for proteins to produce an immune response .
Aug 18, 2022 · The Moderna vaccine after two doses and a first booster dose has been shown to have very high effectiveness against severe disease, hospitalizations and death, and modest effectiveness against symptomatic illness.
Mar 26, 2024 · The NEXTCove clinical trial is a randomized, observer-blind, active-controlled study of approximately 11,400 individuals aged 12 years and older in the United States, United Kingdom and Canada. mRNA-1283 was found to have a similar safety profile to Moderna's approved COVID-19 vaccines.
Download COVID‑19 Vaccine Moderna English language resources for healthcare professionals and patients in Singapore.
Oct 13, 2023 · The Health Sciences Authority (HSA) has on 13 October 2023 authorised the updated Spikevax vaccine by Moderna to be used in Singapore for the prevention of Coronavirus Disease 2019 (COVID-19) in individuals aged 6 months and above.
Nov 1, 2023 · Information about Moderna COVID-19 Vaccine, Bivalent. Updated, bivalent mRNA COVID-19 vaccines are now FDA-authorized for all doses for individuals ages 6 months and older. Moderna COVID-19 ...
v. t. e. The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA).
